IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/11435457

Download in:

View as

General Info

PMID
11435457